mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |